Cefozopran hydrochloride
- CAS No.
- 113981-44-5
- Chemical Name:
- Cefozopran hydrochloride
- Synonyms
- Czop;D02233;Firstcin (tn);Cefozopran hydrochlo;Cefozopran Impurity 1;SCE-2787 hydrochloride;Cefozopran hydrochloride;Cefozopran Hydrochloride RS;Cefozopran hydrochloride (jp15);Cefozopran hydrochloride USP/EP/BP
- CBNumber:
- CB41074592
- Molecular Formula:
- C19H18ClN9O5S2
- Molecular Weight:
- 551.98
- MDL Number:
- MFCD00944908
- MOL File:
- 113981-44-5.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| Cefozopran hydrochloride | NEA98144 | 25mg | $189 |
| Cefozopran hydrochloride | NEA98144 | 100mg | $454 |
| Cefozopran hydrochloride | NEA98144 | 250mg | $907.5 |
| Cefozopran hydrochloride | NEA98144 | 500mg | $1445 |
| Cefozopran hydrochloride | NEA98144 | 1000mg | $2110 |
| More product size | |||
| storage temp. | under inert gas (nitrogen or Argon) at 2-8°C |
|---|---|
| form | Solid |
| color | White to light yellow |
| Water Solubility | Water : ≥ 52 mg/mL (94.20 mM) |
| FDA UNII | 060I5C0GRC |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P280-P301+P312-P302+P352-P305+P351+P338 |
Cefozopran hydrochloride price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Biosynth | NEA98144 | Cefozopran hydrochloride | 113981-44-5 | 25mg | $189 | 2026-06-04 | Buy |
| Biosynth | NEA98144 | Cefozopran hydrochloride | 113981-44-5 | 100mg | $454 | 2026-06-04 | Buy |
| Biosynth | NEA98144 | Cefozopran hydrochloride | 113981-44-5 | 250mg | $907.5 | 2026-06-04 | Buy |
| Biosynth | NEA98144 | Cefozopran hydrochloride | 113981-44-5 | 500mg | $1445 | 2026-06-04 | Buy |
| Biosynth | NEA98144 | Cefozopran hydrochloride | 113981-44-5 | 1000mg | $2110 | 2026-06-04 | Buy |
Cefozopran hydrochloride Chemical Properties,Uses,Production
Uses
Cefozopran (SCE-2787) hydrochloride is a semi-synthetic, parenteral, fourth-generation cephalosporin. Cefozopran hydrochloride, an antibiotic, has a broad spectrum of antibacterial activity, inhibiting most of the gram-negative and gram-positive organisms[1][2].
Antimicrobial activity
Cefazolam hydrochloride is suitable for Staphylococcus, Streptococcus, Enterococcus, Peptostreptococcus, Escherichia coli, Enterobacter, Serratia, Klebsiella, Citrobacter, Proteus, Pseudomonas, Influenza Bacillus, Acinetobacter, Bacteroidetes, septicemia caused by sensitive bacteria to cefazolam hydrochloride, trauma infection, respiratory system, urinary system and abdominal cavity, pelvic purulent inflammation, ophthalmology and ENT inflammation, etc.
Biological Activity
Cefozopran (SCE-2787) hydrochloride is a semi-synthetic, parenteral, fourth-generation cephalosporin. As an antibiotic, it has broad-spectrum antibacterial activity and can inhibit most Gram-negative and Gram-positive bacteria.
in vitro
Cefozopran (SCE-2787) is a fourth-generation cephalosporin that has good activity against gram-positive organisms including methicillin-susceptible staphylococci, enterococci, and viridans group streptococci; and against gram-negative organisms including hemophilus influenza. Moreover, cefozopran has comparatively good activity against enterococci and P. aeruginosa , which are refractory to other cephalosporins.
in vivo
Cefozopran (SCE-2787) (5-80 mg/kg; sc; twice a day for 5 days; four-week-old ICR male mice) is effective against acute respiratory tract infections caused by Kiebsiella pneumonia DT-S. In the model of chronic respiratory tract infection caused by K. pneumoniae 27, Cefozopran (20-80 mg/kg; sc; twice a day for 7 days; five-week-old CBA/J female mice) is as effective as Ceftazidime.
IC 50
β-lactam
References
[1] Sato T, et al. A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders. Pediatr Blood Cancer. 2008;51(6):774-777. DOI:10.1002/pbc.21692
[2] Iizawa Y, et al. Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice. Antimicrob Agents Chemother. 1993;37(1):100-105. DOI:10.1128/AAC.37.1.100
Cefozopran hydrochloride Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 | info@tianfuchem.com | China | 21587 | 55 |
| Cangzhou Wanyou New Material Technology Co.,Ltd | 18631714998 | sales@czwytech.com | CHINA | 904 | 58 |
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19936 | 58 |
| CONIER CHEM AND PHARMA LIMITED | +8618523575427 | sales@conier.com | China | 49979 | 58 |
| career henan chemical co | +86-0371-86658258 +8613203830695 | factory@coreychem.com | China | 29792 | 58 |
| HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6312 | 58 |
| Shaanxi Dideu Medichem Co. Ltd | +86-029-89586680 +86-18192503167 | 1026@dideu.com | China | 9996 | 58 |
| AFINE CHEMICALS LIMITED | +86-0571-85134551 | sales@afinechem.com | China | 15083 | 58 |
| Hefei TNJ Chemical Industry Co.,Ltd. | +86-0551-65418684 +8618949823763 | sales@tnjchem.com | China | 25356 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; | support@targetmol.com | United States | 39039 | 58 |
View Lastest Price from Cefozopran hydrochloride manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2026-04-21 | Cefozopran hydrochloride
113981-44-5
|
$30.00-65.00 | 95.34% | 10g | TargetMol Chemicals Inc. | ||
 |
2020-05-25 | Cefozopran hydrochloride
113981-44-5
|
1KG | 99.0%+ | 300 MT | Shaanxi Dideu Medichem Co. Ltd | ||
 |
2020-01-17 | Cefozopran hydrochloride
113981-44-5
|
$3.00 | 1KG | 98% | 1kg,5kg,50kg | Career Henan Chemical Co |
-
- Cefozopran hydrochloride
113981-44-5
- $30.00-65.00
- 95.34%
- TargetMol Chemicals Inc.
-
- Cefozopran hydrochloride
113981-44-5
- 99.0%+
- Shaanxi Dideu Medichem Co. Ltd
-
- Cefozopran hydrochloride
113981-44-5
- $3.00
- 98%
- Career Henan Chemical Co
